Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials.
adjuvants
antigen-presenting cells
antigens
biomimetic
nanovaccines
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
14 Oct 2019
14 Oct 2019
Historique:
received:
27
08
2019
revised:
09
10
2019
accepted:
11
10
2019
entrez:
17
10
2019
pubmed:
17
10
2019
medline:
17
10
2019
Statut:
epublish
Résumé
The development of vaccines plays a vital role in the effective control of several fatal diseases. However, effective prophylactic and therapeutic vaccines have yet to be developed for completely curing deadly diseases, such as cancer, malaria, HIV, and serious microbial infections. Thus, suitable vaccine candidates need to be designed to elicit appropriate immune responses. Nanotechnology has been found to play a unique role in the design of vaccines, providing them with enhanced specificity and potency. Nano-scaled materials, such as virus-like particles, liposomes, polymeric nanoparticles (NPs), and protein NPs, have received considerable attention over the past decade as potential carriers for the delivery of vaccine antigens and adjuvants, due to their beneficial advantages, like improved antigen stability, targeted delivery, and long-time release, for which antigens/adjuvants are either encapsulated within, or decorated on, the NP surface. Flexibility in the design of nanomedicine allows for the programming of immune responses, thereby addressing the many challenges encountered in vaccine development. Biomimetic NPs have emerged as innovative natural mimicking biosystems that can be used for a wide range of biomedical applications. In this review, we discuss the recent advances in biomimetic nanovaccines, and their use in anti-bacterial therapy, anti-HIV therapy, anti-malarial therapy, anti-melittin therapy, and anti-tumor immunity.
Identifiants
pubmed: 31615112
pii: pharmaceutics11100534
doi: 10.3390/pharmaceutics11100534
pmc: PMC6835828
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : National Research Foundation of Korea
ID : 2014M3C1A3053035, NRF-2017M3A9F5030940 and NRF-2017M3A9E2056374, 2018R1A5A2024181 and NRF-2019M3E5D1A02068082
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Control Release. 2015 Dec 10;219:488-499
pubmed: 26433125
Nat Rev Microbiol. 2015 Aug;13(8):471-83
pubmed: 26179359
Curr Opin Immunol. 2013 Jun;25(3):410-7
pubmed: 23478068
Cancer Lett. 2014 Dec 1;355(1):54-60
pubmed: 25224570
Vaccine. 2002 Dec 20;20 Suppl 5:B10-6
pubmed: 12477412
Tissue Eng Regen Med. 2019 Aug 22;16(5):479-490
pubmed: 31624703
N Engl J Med. 2009 Jan 29;360(5):439-43
pubmed: 19179312
Adv Funct Mater. 2019 Jul 11;29(28):1807616
pubmed: 32313544
Nano Lett. 2015 Feb 11;15(2):1403-9
pubmed: 25615236
Adv Funct Mater. 2016 Mar 8;26(10):1628-1635
pubmed: 27325913
Biol Pharm Bull. 2017;40(6):815-823
pubmed: 28566625
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
J Control Release. 2011 Apr 30;151(2):202-11
pubmed: 21223986
Vaccine. 2012 Oct 19;30(47):6609-11
pubmed: 23067445
Immunol Lett. 2009 Feb 21;122(2):134-6
pubmed: 19100774
Vaccine. 1988 Aug;6(4):304-6
pubmed: 2847436
Biochim Biophys Acta. 2010 Aug;1800(8):691-705
pubmed: 20553812
Antiviral Res. 2010 Jan;85(1):25-33
pubmed: 20018390
J Intern Med. 2015 Oct;278(4):369-95
pubmed: 26212387
PLoS One. 2012;7(2):e31472
pubmed: 22328935
Polymers (Basel). 2018 Sep 25;10(10):
pubmed: 30960988
PLoS One. 2009;4(4):e5409
pubmed: 19404403
Nat Immunol. 2004 Oct;5(10):971-4
pubmed: 15454919
Adv Healthc Mater. 2012 Sep;1(5):537-47
pubmed: 23184788
Front Pharmacol. 2015 Dec 01;6:286
pubmed: 26648870
Parasitology. 1989 Jun;98 Pt 3:381-6
pubmed: 2671876
Nanotheranostics. 2017 Jun 9;1(3):244-260
pubmed: 29071191
Mol Biol Rep. 2018 Dec;45(6):2935-2940
pubmed: 30311129
Expert Opin Drug Deliv. 2011 Apr;8(4):505-19
pubmed: 21413904
Expert Rev Vaccines. 2017 Jan;16(1):55-63
pubmed: 27448771
Gene Ther. 1997 Sep;4(9):891-900
pubmed: 9349425
Vaccine. 1997 Feb;15(3):248-56
pubmed: 9139482
Hum Vaccin Immunother. 2016 Mar 3;12(3):612-22
pubmed: 26513200
Adv Biosyst. 2019 Jan;3(1):e1800219
pubmed: 31728404
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):16998-7003
pubmed: 21949376
Pediatr Nephrol. 2019 Jan;34(1):11-30
pubmed: 29181712
Adv Mater. 2013 Jul 12;25(26):3549-53
pubmed: 23712782
Bioconjug Chem. 2014 Aug 20;25(8):1470-8
pubmed: 25020048
Expert Rev Vaccines. 2011 Apr;10(4):437-46
pubmed: 21506642
Vaccine. 2015 Feb 11;33(7):861-8
pubmed: 25559188
J Clin Invest. 2015 Jun;125(6):2228-33
pubmed: 25893595
AAPS J. 2013 Jan;15(1):85-94
pubmed: 23054976
Vaccine. 2018 Oct 29;36(45):6752-6760
pubmed: 30268733
Nat Med. 2005 Apr;11(4 Suppl):S69-76
pubmed: 15812493
Tissue Eng Regen Med. 2018 Jan 16;15(3):249-261
pubmed: 30603551
Expert Rev Vaccines. 2008 Oct;7(8):1141-50
pubmed: 18844588
Adv Healthc Mater. 2018 Jul;7(13):e1701366
pubmed: 29436150
Int J Nanomedicine. 2017 Feb 14;12:1227-1249
pubmed: 28243086
Tissue Eng Regen Med. 2017 Oct 17;15(1):1-11
pubmed: 30603530
J Struct Biol. 1999 Jun 30;126(3):182-94
pubmed: 10441528
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7
pubmed: 25136134
Adv Mater. 2018 Jun;30(23):e1706759
pubmed: 29582476
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12111-6
pubmed: 22773820
Biotechnol Bioeng. 2015 Jun;112(6):1102-10
pubmed: 25689082
Int Immunopharmacol. 2016 Oct;39:343-352
pubmed: 27526270
J Pharm Sci. 2009 Mar;98(3):812-43
pubmed: 18661544
Science. 1978 Dec 22;202(4374):1290-3
pubmed: 364652
Front Pharmacol. 2018 Aug 14;9:802
pubmed: 30154715
Vaccine. 1990 Mar;8 Suppl:S74-8; discussion S79-80
pubmed: 2139288
Nano Lett. 2019 Jul 10;19(7):4760-4769
pubmed: 31184899
Nat Nanotechnol. 2016 Mar;11(3):295-303
pubmed: 26689376
Biomaterials. 2019 Oct;217:119309
pubmed: 31271855
Front Immunol. 2018 Feb 12;9:90
pubmed: 29483904
Eur J Immunol. 1998 Apr;28(4):1251-61
pubmed: 9565365
Int J Nanomedicine. 2013;8:835-43
pubmed: 23486691
Nanomedicine. 2017 Feb;13(2):515-525
pubmed: 27720930
PLoS One. 2015 Aug 06;10(8):e0134478
pubmed: 26248044
Vaccine. 2000 Jan 6;18(11-12):1051-8
pubmed: 10590325
Methods. 2006 Sep;40(1):60-5
pubmed: 16997714
Biomater Sci. 2017 Feb 28;5(3):378-387
pubmed: 28133653
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1635-1641
pubmed: 31027450
EMBO Mol Med. 2014 May 06;6(6):708-20
pubmed: 24803000
Vaccine. 2016 Nov 21;34(48):5886-5894
pubmed: 27997339
Drug Saf. 2015 Nov;38(11):1059-74
pubmed: 26446142
Tissue Eng Regen Med. 2019 Sep 24;16(5):433-442
pubmed: 31624699
Biomater Res. 2016 Oct 31;20:34
pubmed: 27807476
Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:406-416
pubmed: 28183626
Adv Mater. 2018 Nov;30(45):e1802233
pubmed: 30252965
Vaccine. 2010 Mar 16;28(13):2565-72
pubmed: 20117262
Trends Microbiol. 2003 Sep;11(9):438-44
pubmed: 13678860
Acta Pharmacol Sin. 2005 Apr;26(4):405-16
pubmed: 15780188
Biomater Res. 2018 Sep 26;22:24
pubmed: 30275967
Nanomedicine (Lond). 2016 Jan;11(1):81-100
pubmed: 26653875
Int J Nanomedicine. 2019 Feb 21;14:1401-1410
pubmed: 30863068
Expert Rev Vaccines. 2010 Oct;9(10):1149-76
pubmed: 20923267
PLoS One. 2013;8(3):e60068
pubmed: 23533665
J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S164-70
pubmed: 18520304
Acta Pharm Sin B. 2019 Jul;9(4):675-689
pubmed: 31384529
Nat Commun. 2018 Jan 24;9(1):359
pubmed: 29367723
Enzyme Microb Technol. 2019 Sep;128:40-48
pubmed: 31186109
MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):352-5
pubmed: 24759657
ACS Nano. 2019 Jul 23;13(7):7442-7462
pubmed: 31180642
Nanomedicine (Lond). 2014 Apr;9(4):435-49
pubmed: 24910875
Expert Opin Drug Deliv. 2010 Jul;7(7):829-44
pubmed: 20459361
Bull World Health Organ. 2007 Sep;85(9):719-26
pubmed: 18026629
Vaccine. 2012 Jul 6;30(32):4790-9
pubmed: 22634298
Nanomedicine. 2006 Sep;2(3):137-49
pubmed: 17292136
Adv Ther (Weinh). 2019 May;2(5):
pubmed: 33969181
Tissue Eng Regen Med. 2018 Jun 21;15(4):365-380
pubmed: 30603561
Tissue Eng Regen Med. 2019 Apr 23;16(3):213-223
pubmed: 31205851
Eur J Immunol. 2005 Jul;35(7):2031-40
pubmed: 15971275
Nano Lett. 2016 Sep 14;16(9):5895-901
pubmed: 27513184
Nature. 2015 Oct 1;526(7571):118-21
pubmed: 26374997
Gene Ther. 1998 Jul;5(7):930-7
pubmed: 9813664
Adv Healthc Mater. 2015 Aug 5;4(11):1645-52
pubmed: 25960053
Nano Lett. 2018 Oct 10;18(10):6164-6174
pubmed: 30207473
Vaccine. 2017 Oct 4;35(41):5448-5454
pubmed: 28274638
Subcell Biochem. 2013;68:53-75
pubmed: 23737048
Nat Nanotechnol. 2013 Dec;8(12):933-8
pubmed: 24292514
J Immunol. 2018 Nov 15;201(10):2969-2976
pubmed: 30333124
Oncoimmunology. 2013 Jan 1;2(1):e23687
pubmed: 23483762
Biomaterials. 2016 Aug;97:85-96
pubmed: 27162077
ACS Nano. 2014 May 27;8(5):4975-83
pubmed: 24716550
BMC Cancer. 2019 May 15;19(1):454
pubmed: 31092229
Nanomedicine (Lond). 2010 Feb;5(2):269-85
pubmed: 20148638
ACS Nano. 2018 Jun 26;12(6):5121-5129
pubmed: 29771487
Tissue Eng Regen Med. 2018 Aug 14;15(6):735-750
pubmed: 30603592
J Mater Chem B. 2016 Sep 7;4(33):5496-5509
pubmed: 30774955
Malar J. 2011 Aug 04;10:224
pubmed: 21816029
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):10980-5
pubmed: 21690347
Chem Rev. 2015 Oct 14;115(19):10907-37
pubmed: 26166537
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Curr Opin Immunol. 2011 Jun;23(3):436-43
pubmed: 21570272
ACS Appl Mater Interfaces. 2016 Feb;8(7):4407-15
pubmed: 26824329
ACS Nano. 2018 Jun 26;12(6):5241-5252
pubmed: 29800517
Expert Rev Vaccines. 2007 Aug;6(4):559-78
pubmed: 17669010
J Extracell Vesicles. 2014 Aug 11;3:
pubmed: 25147647
Curr Top Microbiol Immunol. 2009;333:269-89
pubmed: 19768411
Sci Rep. 2017 Apr 19;7:46621
pubmed: 28422178
J Exp Med. 1937 Nov 30;66(6):761-88
pubmed: 19870697
Tissue Eng Regen Med. 2019 Oct 1;16(5):451-465
pubmed: 31624701
Adv Mater. 2017 Dec;29(47):
pubmed: 29239517
Hum Vaccin Immunother. 2016 Apr 2;12(4):990-2
pubmed: 26810033
Sci Rep. 2017 Oct 23;7(1):13743
pubmed: 29062078
PLoS One. 2012;7(8):e42363
pubmed: 22879951
Adv Mater. 2017 Sep;29(35):
pubmed: 28722140
Pharm Res. 2011 Feb;28(2):215-36
pubmed: 20721603
Int J Nanomedicine. 2018 Jun 01;13:3251-3261
pubmed: 29910613
J Acquir Immune Defic Syndr (1988). 1994 Aug;7(8):799-806
pubmed: 8021814
Nature. 2013 Jul 4;499(7456):102-6
pubmed: 23698367
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
Immunol Lett. 2016 Aug;176:57-64
pubmed: 27260485
Vaccine. 2008 Apr 24;26(18):2225-33
pubmed: 18396362
J Immunother. 2007 Jul-Aug;30(5):469-78
pubmed: 17589287
Nanoscale. 2019 Apr 23;11(16):7996-8011
pubmed: 30969294
Vaccine. 2016 Oct 17;34(44):5344-5351
pubmed: 27633665
Genes Dev. 2005 Nov 15;19(22):2645-55
pubmed: 16291643
Adv Ther (Weinh). 2018 Jun;1(2):
pubmed: 30320205
Chem Biol Drug Des. 2012 Sep;80(3):349-57
pubmed: 22650354
Polymers (Basel). 2018 Sep 03;10(9):
pubmed: 30960908